全文获取类型
收费全文 | 1489篇 |
免费 | 166篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 102篇 |
妇产科学 | 26篇 |
基础医学 | 132篇 |
口腔科学 | 53篇 |
临床医学 | 144篇 |
内科学 | 445篇 |
皮肤病学 | 30篇 |
神经病学 | 35篇 |
特种医学 | 203篇 |
外科学 | 100篇 |
综合类 | 116篇 |
预防医学 | 86篇 |
眼科学 | 19篇 |
药学 | 126篇 |
中国医学 | 5篇 |
肿瘤学 | 76篇 |
出版年
2023年 | 21篇 |
2022年 | 20篇 |
2021年 | 44篇 |
2020年 | 31篇 |
2019年 | 18篇 |
2018年 | 28篇 |
2017年 | 49篇 |
2016年 | 44篇 |
2015年 | 37篇 |
2014年 | 75篇 |
2013年 | 92篇 |
2012年 | 38篇 |
2011年 | 48篇 |
2010年 | 73篇 |
2009年 | 84篇 |
2008年 | 46篇 |
2007年 | 89篇 |
2006年 | 52篇 |
2005年 | 44篇 |
2004年 | 48篇 |
2003年 | 29篇 |
2002年 | 23篇 |
2001年 | 35篇 |
2000年 | 15篇 |
1999年 | 21篇 |
1998年 | 79篇 |
1997年 | 69篇 |
1996年 | 63篇 |
1995年 | 54篇 |
1994年 | 46篇 |
1993年 | 47篇 |
1992年 | 13篇 |
1991年 | 9篇 |
1990年 | 17篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 13篇 |
1986年 | 22篇 |
1985年 | 19篇 |
1984年 | 12篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1969年 | 3篇 |
排序方式: 共有1707条查询结果,搜索用时 16 毫秒
41.
Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene 总被引:3,自引:0,他引:3
Yeowell-O'Connell K; Rothman N; Smith MT; Hayes RB; Li G; Waidyanatha S; Dosemeci M; Zhang L; Yin S; Titenko-Holland N; Rappaport SM 《Carcinogenesis》1998,19(9):1565-1571
Benzene oxide (BO) reacts with cysteinyl residues in hemoglobin (Hb) and
albumin (Alb) to form protein adducts (BO-Hb and BO-Alb), which are
presumed to be specific biomarkers of exposure to benzene. We analyzed
BO-Hb in 43 exposed workers and 42 unexposed controls, and BO-Alb in a
subsample consisting of 19 workers and 19 controls from Shanghai, China, as
part of a larger cross-sectional study of benzene biomarkers. The adducts
were analyzed by gas chromatography-mass spectrometry following reaction of
the protein with trifluoroacetic anhydride and methanesulfonic acid. When
subjects were divided into controls (n = 42) and workers exposed to < or
=31 (n = 21) and >31 p.p.m. (n = 22) benzene, median BO-Hb levels were
32.0, 46.7 and 129 pmol/g globin, respectively (correlation with exposure:
Spearman r = 0.67, P < 0.0001). To our knowledge, these results
represent the first observation in humans that BO-Hb levels are
significantly correlated with benzene exposure. Median BO-Alb levels in
these 3 groups were 103 (n = 19), 351 (n = 7) and 2010 (n = 12) pmol/g Alb,
respectively, also reflecting a significant correlation with exposure
(Spearman r = 0.90, P < 0.0001). The blood dose of BO predicted from
both Hb and Alb adducts was very similar. These results clearly affirm the
use of both Hb and Alb adducts of BO as biomarkers of exposure to high
levels of benzene. As part of our investigation of the background levels of
BO-Hb and BO-Alb found in unexposed persons, we analyzed recombinant human
Hb and Alb for BO adducts. Significant levels of both BO-Hb (19.7 pmol/g)
and BO-Alb (41.9 pmol/g) were detected, suggesting that portions of the
observed background adducts reflect an artifact of the assay, while other
portions are indicative of either unknown exposures or endogenous
production of adducts.
相似文献
42.
Liu JM; Chen YM; Chao Y; Liu SM; Tiu CM; Wu HW; Chiou TC; Hsieh RK; Chen LT; Whang-Peng J 《Japanese journal of clinical oncology》1998,28(7):431-435
BACKGROUND: To evaluate the efficacy and toxicity of cisplatin/etoposide
continuous infusion chemotherapy for cancer of unknown primary site in
Taiwan, a region with a high prevalence of endemic viral infections.
METHOD: Between April 1994 and February 1996, 20 patients with a diagnosis
of CUPS were treated, including 15 males and five females, of average age
63.3 years (range 41-83 years). Continuous intravenous infusion of
etoposide 80 mg/m2 and cisplatin 25 mg/m2 was given for 3 days every 3
weeks. Pretreatment tumor marker and viral serology studies were performed
for baseline evaluation. Nearly two-thirds of the patients had poorly
differentiated carcinoma. The average number of metastatic sites was 2.65
(range 1-4), with liver and lymph node involvement predominating. RESULTS:
The overall response rate was 25% (95% CI 17.7-32.3%); 30.7% for poorly
differentiated cancers and 25% for well differentiated cancers. Median
survival was 4 months (range 1-12 months), 4.8 months for patients
attaining partial response. Toxicity was moderate, grade 3 and 4
neutropenia occurred in 55% and grade 3 and 4 thrombocytopenia in 40%;
other toxicities were mild. CA125 and CA199 were elevated in more than 50%
of patients. Viral serology studies were not significantly different from
those of the indigenous population. CONCLUSION: Etoposide and cisplatin
combination chemotherapy has modest activity in patients with extensive
CUPS and, at the schedule and dosage given, it is associated with moderate
toxicity.
相似文献
43.
44.
45.
46.
47.
48.
49.